Home » Topics » BioWorld Science

BioWorld Science
RSS

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Dec. 21, 2021

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

Dec. 21, 2021

IFI27 as a potential new gene biomarker for severe COVID-19

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

P38 targeting reverses immunosuppressive tumor microenvironment in metastatic breast cancer

Dec. 21, 2021

Novel XO inhibitors show efficacy in acute hyperuricemia rat model

Dec. 21, 2021

Mouse model of metaplastic breast cancer with conditional overexpression of TRIM24

Dec. 21, 2021

MCC-1734 inhibits cancer cells with different resistance mechanisms

Dec. 21, 2021

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

Dec. 21, 2021

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...